Phylogenetic Analysis of the repleta Species Group of the Genus Drosophila Using Multiple Sources of Characters von Durando, Celeste M., Baker, Richard H., Etges, William J., Heed, William B., Wasserman, Marvin, DeSalle, Rob

Volltext

Genetic divergence within the Drosophila mayaguana subcluster, a closely related triad of Caribbean species in the repleta species group von O'GRADY, P. M., DURANDO, C. M., HEED, W. B., WASSERMAN, M., ETGES, W., DESALLE, R.

Volltext

Genetic divergence within the Drosophila mayaguana subcluster, a closely related triad of Caribbean species in the repleta species group von O'Grady, P M, Durando, C M, Heed, W B, Wasserman, M, Etges, W, Desalle, R

Volltext

Polytene chromosomes as indicators of phylogeny in several species groups of Drosophila von O'Grady, P M, Baker, R H, Durando, C M, Etges, W J, DeSalle, R

Volltext

A vascular flora of the forested portion of Cunningham Park, Queens County, New York: corrections and additions. III von Greller, A.M. (Queens College, CUNY, Flushing, NY), Panuccio, M.K, Durando, C.M

Volltext

Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial von Del Mastro, Lucia, Dr, De Placido, Sabino, Prof, Bruzzi, Paolo, MD, De Laurentiis, Michele, MD, Boni, Corrado, MD, Cavazzini, Giovanna, MD, Durando, Antonio, MD, Turletti, Anna, MD, Nisticò, Cecilia, MD, Valle, Enrichetta, MD, Garrone, Ornella, MD, Puglisi, Fabio, MD, Montemurro, Filippo, MD, Barni, Sandro, MD, Ardizzoni, Andrea, MD, Gamucci, Teresa, MD, Colantuoni, Giuseppe, MD, Giuliano, Mario, MD, Gravina, Adriano, MD, Papaldo, Paola, MD, Bighin, Claudia, MD, Bisagni, Giancarlo, MD, Forestieri, Valeria, MD, Cognetti, Francesco, MD

Volltext

Determinants of adherence to seasonal influenza vaccination among healthcare workers from an Italian region: results from a cross-sectional study von Durando, P, Alicino, C, Dini, G, Barberis, I, Bagnasco, A M, Iudici, R, Zanini, M, Martini, M, Toletone, A, Paganino, C, Massa, E, Orsi, A, Sasso, L

Volltext

Paracetamol (acetaminophen) rescues cognitive decline, neuroinflammation and cytoskeletal alterations in a model of post-operative cognitive decline (POCD) in middle-aged rats von Garrone, B., Durando, L., Prenderville, J., Sokolowska, E., Milanese, C., Di Giorgio, F. P., Callaghan, C., Bianchi, M.

Volltext

Prenatal Bisphenol a Exposure Induces Preneoplastic Lesions in the Mammary Gland in Wistar Rats von Milena Durando, Laura Kass, Julio Piva, Sonnenschein, Carlos, Soto, Ana M., Enrique H. Luque, Mónica Muñoz-de-Toro

Volltext

Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections von Bassetti, M., Repetto, E., Righi, E., Boni, S., Diverio, M., Molinari, M. P., Mussap, M., Artioli, S., Ansaldi, F., Durando, P., Orengo, G., Bobbio Pallavicini, F., Viscoli, C.

Volltext

Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial von Oza, Amit M, Prof, Cook, Adrian D, MSc, Pfisterer, Jacobus, Prof, Embleton, Andrew, MSc, Ledermann, Jonathan A, Prof, Pujade-Lauraine, Eric, Prof, Kristensen, Gunnar, Prof, Carey, Mark S, MD, Beale, Philip, MD, Cervantes, Andrés, Prof, Park-Simon, Tjoung-Won, Prof, Rustin, Gordon, Prof, Joly, Florence, Prof, Mirza, Mansoor R, MD, Plante, Marie, MD, Quinn, Michael, Prof, Poveda, Andrés, MD, Jayson, Gordon C, Prof, Stark, Dan, MD, Swart, Ann Marie, Prof, Farrelly, Laura, MSc, Kaplan, Richard, Prof, Parmar, Mahesh K B, Prof, Perren, Timothy J, Prof

Volltext

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial von Kerbrat, Pierre, Fumoleau, Pierre, Jacquin, Jean-Philippe, Abadie-Lacourtoisie, Sophie, Cany, Laurent, Khayat, David, Paget-Bailly, Sophie, Demarchi, F, N'Guyen, T, Stein, U, Villanueva, C, Guimont, I, Lévy, E, Delbaldo, C, Pouessel, D, Fournel-Fédérico, C, Freyer, G, Tartas, S, Bons, F, Cuvier, C, Hajjaji, N, Capitain, O, Maillart, P, Bonnefoi, H, Durand, M, Madranges, N, Mauriac, L, Durando, X, Durieux, A, Piperno-Neumann, S, Tresca, P, Ferrant, E, Mayer, F, Vanneuville, AC, Servent, V, Guastalla, JP, Biron, P, Dupuy-Brousseau, L, Lancry, L, Trédan, O, Extra, JM, Berton-Rigaud, D, Ferrero, JM, Largillier, R, Gedoin, D, Laguerre, B, Lefeuvre, C, Vauléon, E, Tennevet, I, Mefti-Lacheraf, F, Dalenc, F, André, F, Domont, J, Ezenfis, J, Provençal, J, Bellaiche-Miccio, C, Boutan-Laroze, G, Arsène, O, Merad-Boudia, Z, Orfeuvre, H, Lamy, R, Sarda, C, Salles, B, Cauvin, I, Mangold, M, Bourcier, A, Geay, JF, ElAmarti, R, Combe, M, Dauba, J, Denizon, N, Clavreul, G, Goubely, Y, Delecroix, V, Ligeza-Poisson, V, Leyronnas, C, Teissier, E, Bernard, O, Pottier-Kyndt, V, Drony, S, Moriceau, M, Besson, D, Achille, E, Moran-Ribon, A, Moullet, I, Couderc, B, Burki, F, Schaeffer, F, Montcuquet, P, Baumont, GA, Gréget, S, Ratoanina, JL, Bonichon-Lamichhane, M, Cartron, G, Dupuis, O, Ganem, G, LeRol, A, Antoine, EC, Llory, JF, Loiseau, D

Volltext

6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial von Pivot, Xavier, Prof, Romieu, Gilles, MD, Debled, Marc, MD, Pierga, Jean-Yves, Prof, Kerbrat, Pierre, Prof, Bachelot, Thomas, MD, Lortholary, Alain, MD, Espié, Marc, MD, Fumoleau, Pierre, Prof, Serin, Daniel, MD, Jacquin, Jean-Philippe, MD, Jouannaud, Christelle, MD, Rios, Maria, MD, Abadie-Lacourtoisie, Sophie, MD, Tubiana-Mathieu, Nicole, Prof, Cany, Laurent, MD, Catala, Stéphanie, MD, Khayat, David, Prof, Pauporté, Iris, PhD, Kramar, Andrew, PhD

Volltext

Phase 1 trial of ralimetinib (LY2228820) with radiotherapy plus concomitant temozolomide in the treatment of newly diagnosed glioblastoma von Biau, J., Thivat, E., Chautard, E., Stefan, D., Boone, M., Chauffert, B., Bourgne, C., Richard, D., Molnar, I., Levesque, S., Bellini, R., Kwiatkowski, F., Karayan-Tapon, L., Verrelle, P., Godfraind, C., Durando, X.

Volltext

Quality of life after mastectomy with or without immediate breast reconstruction von Dauplat, J., Kwiatkowski, F., Rouanet, P., Delay, E., Clough, K., Verhaeghe, J. L., Raoust, I., Houvenaeghel, G., Lemasurier, P., Thivat, E., Pomel, C., Abrial, C., Afonso, J., Bannier, M., Body, G., Baron, M., Bergzoll, C., Chauvet, M. P., Classe, J. M., Cothier‐Savey, I., Dejode, M., Dessogne, P., Doridot, V., Durando, X., Faucher, A., Faure, C., Figl, A., Fitoussi, A., Flipo, B., Fondrinier, E., Garbay, J. R., Giacalone, P. L., Gimbergue, P., Guillemin, F., Gutowski, M., Houpeau, J. L., Inguenault, C., Lambaudie, E., Lantieri, L., Le Bouedec, G., Lepage, C., Loustalot, C., Machiavello, J. C., Monrigal, E., Mourregot, A., Nos, C., Paradol, P. O., Rimareix, F., Rodier, J. F., Rouzier, R., Saint‐Aubert, B., Salmon, R. J., Scherer, C., Toussoun, G., Tunon de Lara, C., Uzan, S., Weitbruch, D.

Volltext

Multicentric neoadjuvant pilot Phase II study of cetuximab combined with docetaxel in operable triple negative breast cancer von Nabholtz, J.M., Chalabi, N., Radosevic‐Robin, N., Dauplat, M.M., Mouret‐Reynier, M.A., Van Praagh, I., Servent, V., Jacquin, JP, Benmammar, K.E., Kullab, S., Bahadoor, M.R.K., Kwiatkowski, F., Cayre, A., Abrial, C., Durando, X., Bignon, Y.J., Chollet, P., Penault‐Llorca, F.

Volltext

Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable... von Chauffert, B., Feuvret, L., Bonnetain, F., Taillandier, L., Frappaz, D., Taillia, H., Schott, R., Honnorat, J., Fabbro, M., Tennevet, I., Ghiringhelli, F., Guillamo, J.S., Durando, X., Castera, D., Frenay, M., Campello, C., Dalban, C., Skrzypski, J., Chinot, O.

Volltext

Radiotherapy plus temozolomide in elderly patients with glioblastoma: a "real-life" report von Biau, J, Chautard, E, De Schlichting, E, Dupic, G, Pereira, B, Fogli, A, Müller-Barthélémy, M, Dalloz, P, Khalil, T, Dillies, A F, Durando, X, Godfraind, C, Verrelle, P

Volltext

Effects of Topically Administered Neuroprotective Drugs in Early Stages of Diabetic Retinopathy: Results of the EUROCONDOR Clinical Trial von Simó, Rafael, Hernández, Cristina, Porta, Massimo, Bandello, Francesco, Grauslund, Jakob, Harding, Simon P, Aldington, Stephen J, Egan, Catherine, Frydkjaer-Olsen, Ulrik, García-Arumí, José, Gibson, Jonathan, Lang, Gabriele E, Lattanzio, Rosangela, Massin, Pascale, Midena, Edoardo, Ponsati, Berta, Ribeiro, Luísa, Scanlon, Peter, Lobo, Conceição, Costa, Miguel Ângelo, Cunha-Vaz, José

Volltext

Weekly paclitaxel as a single agent or in combination with carboplatin or weekly topotecan in patients with resistant ovarian cancer: the CARTAXHY randomized phase II trial from Gr... von Lortholary, A., Largillier, R., Weber, B., Gladieff, L., Alexandre, J., Durando, X., Slama, B., Dauba, J., Paraiso, D., Pujade-Lauraine, E.

Volltext